Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV16 SLP vaccination with or without imiquimod in HPV16-positive high-grade VIN/VaIN
NL-OMON21989Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2008
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in vulvar intraepithelial neoplasia (VIN), vaginal intraepithelial neoplasia (VAIN) and HPV16 infection (HPV16) comparing ISA-HPV-01 + imiquimod with ISA-HPV-01 alone (2 arms). Started Oct 2008; status: recruiting.
02
Drugs
SLP-HPV-01imiquimod
03
Conditions
vulvar intraepithelial neoplasia (VIN)vaginal intraepithelial neoplasia (VAIN)HPV16 infection (HPV16)
Beyond the preview
Go deeper on NL-OMON21989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21989.